Prevention of Infection: Transplant

Prevention of Infection: Transplant

Autologous hematopoietic stem cell transplant (HSCT) recipients tend to have fewer infectious complications than allogeneic transplant recipients; however, defects in cell-mediated immunity can continue for months, even in uncomplicated HSCTs of both types. Patients undergoing transplantation are at high risk for infection with a variety of pathogens at multiple phases in their care. This section includes evidence for preventing infections in the transplant patient population.

Click here for instructions on navigating the ONS PEP webpages. Have a question about how to apply this PEP topic to your practice? Ask a nurse on ONS staff at

This topic was updated on March 19, 2018.

About This Topic

Other Resources